Amanda Feilding

Amanda Feilding, the Countess of Wemyss and March, is a distinguished British artist, scientist, and advocate for drug policy reform. In 1998, she established the Beckley Foundation, a charitable organization dedicated to fostering a sensible, evidence-driven framework for global drug policy. Under her leadership, the foundation has spearheaded groundbreaking neuroscientific and clinical studies that explore the impact of psychoactive substances on both brain function and cognitive processes.

Feilding's work goes beyond research; she is also committed to exploring innovative treatment options for a variety of mental and physical health issues, as well as seeking methods to enhance creativity and overall well-being. Her efforts have positioned her as a leading figure in the dialogue surrounding drug policy reform, emphasizing the importance of scientific understanding in shaping public policy.

Throughout her career, Feilding has been recognized for her contributions to both the arts and sciences, effectively bridging the gap between the two fields. Her pioneering research and advocacy work continue to influence the landscape of drug policy, promoting a shift towards a more informed and compassionate approach to substance use and mental health treatment. Through her initiatives, Amanda Feilding remains at the forefront of efforts to transform perspectives on psychoactive substances and their potential benefits.